Search results
Results from the WOW.Com Content Network
The respiratory center of the brain is located in the pons and medulla and is primarily driven by elevated carbon dioxide levels in the blood (hypercapnia) with decreased oxygen levels serving as a less potent stimulus. [9] Central nervous system disorders, such as stroke and tumors, may cause hypoventilation. Drugs may decrease respiratory ...
Like other β adrenergic agonists, they cause smooth muscle relaxation. β 2 adrenergic agonists' effects on smooth muscle cause dilation of bronchial passages, vasodilation in muscle and liver, relaxation of uterine muscle, and release of insulin. They are primarily used to treat asthma and other pulmonary disorders.
Initially CO 2 was thought to work through anoxia, but in the early 1900, increased CO 2 in the lung showed a dramatic increase oxygenation of the brain disproving the anoxia argument. [11] Prior to the development of modern anesthetics, CO 2 was used extensively by psychiatrists in a treatment called carbon dioxide inhalation therapy.
New guidelines say ‘greenhouse gas effect’ of treatment compares to environmental impact of long car journey Doctors urged to ditch blue inhalers for asthma treatment over climate concerns ...
Some known causes that increase the risk of having a panic attack include medical and psychiatric conditions (e.g., panic disorder, social anxiety disorder, post-traumatic stress disorder, substance use disorder, depression), substances (e.g., nicotine, caffeine), and psychological stress.
Methoxyflurane, sold under the brand name Penthrox among others, is an inhaled medication primarily used to reduce pain following trauma. [5] [6] It may also be used for short episodes of pain as a result of medical procedures. [4]
Two new studies suggest once again the importance of getting a good night's sleep for good health over a lifetime, as scientists pursue new understandings of restorative deep sleep.
Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim.